These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 26172050)
21. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia. Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612 [No Abstract] [Full Text] [Related]
22. Psychiatric adverse drug reactions in the paediatric population. Ekhart C; Vries T; Hunsel FV Arch Dis Child; 2020 Aug; 105(8):749-755. PubMed ID: 32060030 [TBL] [Abstract][Full Text] [Related]
23. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Jose J; Rao PG Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163 [TBL] [Abstract][Full Text] [Related]
24. Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands. Glerum PJ; Maliepaard M; de Valk V; Scholl JHG; van Hunsel FPAM; van Puijenbroek EP; Burger DM; Neef K Clin Transl Sci; 2020 May; 13(3):599-607. PubMed ID: 32052597 [TBL] [Abstract][Full Text] [Related]
25. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports. Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening]. Yang W; Xiang YY; Xie YM; Shen H Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322 [TBL] [Abstract][Full Text] [Related]
27. Adverse drug reactions experience in a teaching hospital in Jordan. Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340 [TBL] [Abstract][Full Text] [Related]
28. Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014. Awodele O; Ibrahim A; Orhii P Int J Risk Saf Med; 2016 Mar; 28(1):13-23. PubMed ID: 27176753 [TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database. Kim HK; Jang KS; Kim DW Epilepsy Behav; 2024 May; 154():109784. PubMed ID: 38636107 [TBL] [Abstract][Full Text] [Related]
30. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database. Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262 [TBL] [Abstract][Full Text] [Related]
31. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. Montastruc JL; Lapeyre-Mestre M; Bagheri H; Fooladi A Fundam Clin Pharmacol; 2002 Oct; 16(5):343-6. PubMed ID: 12608357 [TBL] [Abstract][Full Text] [Related]
32. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department. Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501 [TBL] [Abstract][Full Text] [Related]
33. Detection of adverse drug reactions among ordinary users of liraglutide on the occasion of drug dispensing in the community pharmacy setting. Christensen ST; Bjerrum OJ J Patient Saf; 2013 Dec; 9(4):219-23. PubMed ID: 24257065 [TBL] [Abstract][Full Text] [Related]
34. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®. Svendsen K; Wood M; Olsson E; Nordeng H Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074 [TBL] [Abstract][Full Text] [Related]
35. Pharmacovigilance in children in Camagüey Province, Cuba. Bárzaga Arencibia Z; López Leyva A; Mejías Peña Y; González Reyes AR; Fernández Manzano E; Choonara I Eur J Clin Pharmacol; 2012 Jul; 68(7):1079-84. PubMed ID: 22315149 [TBL] [Abstract][Full Text] [Related]
36. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence. Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831 [TBL] [Abstract][Full Text] [Related]
37. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands. Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243 [TBL] [Abstract][Full Text] [Related]
38. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions. More SA; Atal S; Mishra PS J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933 [TBL] [Abstract][Full Text] [Related]
39. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance. Fornasier G; Taborelli M; Francescon S; Polesel J; Aliberti M; De Paoli P; Baldo P Int J Clin Pharm; 2018 Aug; 40(4):795-802. PubMed ID: 29785683 [TBL] [Abstract][Full Text] [Related]
40. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database. Montastruc F; Duguet C; Rousseau V; Bagheri H; Montastruc JL Eur J Clin Pharmacol; 2014 Sep; 70(9):1123-7. PubMed ID: 24925091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]